Although exercise remains the preferred method of cardiac stress testing, pharmacological stress plays an important role in nuclear cardiology. The globally ageing population will see an expansion of the application of pharmacological stress testing, and with this, comes the need to understand the pharmacological basis, mechanisms of action, potential interactions and adverse effects to inform usage in less-than-ideal circumstances. This study aims to enhance the decision-making process in day-to-day clinical nuclear cardiology practice through a better understanding of nuances relevant to the pharmacological agents used for cardiac stress testing.
aFaculty of Science
bCentre for Research in Complex Systems, Charles Sturt University, Wagga Wagga
cAustralian School of Advanced Medicine, Macquarie University
dCardiac Health Institute, Sydney, Australia
Correspondence to Professor Geoffrey M. Currie, MedRadSc, MAppMngt, MBA, PhD, Faculty of Science, Charles Sturt University, Locked Bag 588, Wagga Wagga 2678, Australia Tel: +2 693 32822; fax: +2 693 32588; e-mail: firstname.lastname@example.org
Received January 13, 2011
Accepted February 21, 2011